EBOS Group Limited (EBO) Gets a Buy from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Ramsay Health Care. According to TipRanks, Sutcliffe has an average return of 1.3% and a 50.29% success rate on recommended stocks. EBOS Group Limited has an analyst consensus of Strong Buy, with a price target consensus of A$23.81.
Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50.
Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Ramsay Health Care. According to TipRanks, Sutcliffe has an average return of 1.3% and a 50.29% success rate on recommended stocks.
EBOS Group Limited has an analyst consensus of Strong Buy, with a price target consensus of A$23.81.